|
|
GRUPO IA |
24 |
|
GRUPO IB |
147 |
|
GRUPO IIA |
69 |
|
GRUPO IIB |
177 |
|
|
< 24 Sem/Feto + N=24 |
|
<24 Sem/Vivos N=147 |
|
> 24 Sem/Feto + N=69 |
|
> 24 Sem/Vivos N=177 |
|
|
Muestra |
Porcentaje |
|
Muestra |
Porcentaje |
|
Muestra |
Porcentaje |
|
Muestra |
Porcentaje |
| HIV |
|
6 |
25,00% |
|
67 |
45,58% |
|
8 |
11,59% |
|
69 |
38,98% |
| MIP |
|
13 |
54,17% |
|
63 |
42,86% |
|
30 |
43,48% |
|
64 |
36,16% |
| EXCRECENCIAS |
|
1 |
4,17% |
|
3 |
2,04% |
|
0 |
0,00% |
|
16 |
9,04% |
| DILATACION |
|
1 |
4,17% |
|
1 |
0,68% |
|
0 |
0,00% |
|
24 |
13,56% |
| HIFROCEFALIA |
|
0 |
0,00% |
|
0 |
0,00% |
|
0 |
0,00% |
|
3 |
1,69% |
| HSA |
|
4 |
16,67% |
|
24 |
16,33% |
|
10 |
14,49% |
|
50 |
28,25% |
| FIBROSIS |
|
0 |
0,00% |
|
0 |
0,00% |
|
0 |
0,00% |
|
13 |
7,34% |
| EDEMA |
|
2 |
8,33% |
|
14 |
9,52% |
|
5 |
7,25% |
|
30 |
16,95% |
| NECROSIS SB |
|
0 |
0,00% |
|
0 |
0,00% |
|
0 |
0,00% |
|
10 |
5,65% |
| GLIOSIS SB |
|
0 |
0,00% |
|
0 |
0,00% |
|
5 |
7,25% |
|
38 |
21,47% |
| NNA |
|
0 |
0,00% |
|
1 |
0,68% |
|
12 |
17,39% |
|
22 |
12,43% |
| EHI |
|
0 |
0,00% |
|
0 |
0,00% |
|
5 |
7,25% |
|
27 |
15,25% |
| CALCIFICACIONES |
|
0 |
0,00% |
|
0 |
0,00% |
|
3 |
4,35% |
|
10 |
5,65% |
| INFARTO |
|
0 |
0,00% |
|
0 |
0,00% |
|
0 |
0,00% |
|
7 |
3,95% |
| GLIOSIS SG |
|
0 |
0,00% |
|
0 |
0,00% |
|
0 |
0,00% |
|
11 |
6,21% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|